The present invention comprises dosing regimens and formulations of islet ce ll neogenesis associated protein (INGAP) and INGAP Peptide. The formulation disclosed herein is shown have acceptable stability as a pharmaceutical composition. Further, the formulation is able to regenerate functional islet s
申请公布号
CA2463769(A1)
申请公布日期
2003.04.24
申请号
CA20022463769
申请日期
2002.10.15
申请人
GMP ENDOTHERAPEUTICS, INC.
发明人
PITTENGER, GARY;VINIK, AARON I.;TAYLOR-FISHWICK, DAVID;SALEM, MICHAEL;MOHRLAND, SCOTT;ROSENBERG, LAWRENCE
